Digital Therapeutics for patients with neurodegenerative diseases
History, Investment, and News
During the past year, Emocog raised funds and
established partnerships with renowned companies worldwide.
Establishment of Emocog, Inc.
Establishment and certification of in-house research institute
Secured 23 related patents (9 registered, 14 filed)
Signed MOU with Eisai Korea
Joined the Digital Therapeutics Alliance (DTA) membership
Seed Funding Round
Pre-Series A Funding Round
Green Cross Holdings
GMP certification for clinical trials
Development of Cogthera 2.0
Participated in CES 2022
Establishment of Cogthera GmbH in Germany
Cogthera US FDA Pre-submission
IFA, 5-HT Germany Startup Pitch Winner
Samsung Finance Open Collaboration: Excellence Prize Winner
Cogthera certified for clinical trials
NSR Report By US FDA Complete
Acquired Happymind (90% Market Share for ADHD Digital Diagnostics Tool)
Cogthera GmbH joins the 5-HT Digital Hub "Healthcare for Pharma" in Germany
Initiated Pivotal Trials for Cogthera in Korea
Cogthera: Designated as the 35th Innovative Medical Device (Cutting Edge Technologies Sector)
Development of MemoryPick(기억콕콕)
The founders of Emocog are all medical professors and experts. Our employees are from leading companies around the world, united by a global mindset and a strong passion for what we do.
Jun Young Lee
Seoul National University College of Medicine, PhD (Psychiatry)
Professor at Seoul National University College of Medicine (Psychiatry)
Korean Elderly Psychiatric Association
Director of Society for Cognitive Intervention
Yoo Hun Noh
Chung-Ang University College of Medicine, PhD
Former Professor at Chung-Ang University College of Medicine (Human Anatomy)
Consulting Member at KISTEP
Jung Hae Youn
Paris 7, PhD
CEO of Cha Psychological Counseling Center
Professor at Cha University College of Medicine (Psychology)
Chief Operating Officer
Seul Gyu Park
Sciences Po Paris, Master’s
M&A, Finance & Corporate Strategy
Former Big 4 Management Consulting
Chief Strategy Officer / CEO Europe
Heidelberg University, Bachelor’s (Economics)
M&A, Finance & Corporate Strategy
Sciences Po Paris Master’s (Economics/Business Management)
Former M&A and Finance at Siemens, Germany, Portugal & Switzerland
EVP / Chief Medical Officer
June Sik Mune
Seoul National University College of Medicine, Bachelor's
Soonchunyang University College of Medicine, PhD
Former LG Chem, Head of Clinical Development Center
Chief Business Officer
Korea University, Bachelor’s
Merck-Harvard Executive Business School
Former Head of Domestic and International Strategy, Business Development, Marketing, Sales at Global Pharmaceutical Company, Merck (MSD)
Chief Technology Officer
Seoul National University, Bachelor’s
(Computer Science and Engineering)
Former SAP Software Engineer
Cogthera constantly monitors the conditions of patients' cognitive functions and provides personalized cognitive training to strengthen the neural networks, which increases the 'cognitive reserve' and helps with memory.
The app's contents are derived from the concept of Metamemory training, the subject of our founders' long-year research.
*Cognitive reserve: a concept introduced from the distinction between neuropathological and clinical severity of the brain;
one of the factors that determine the prevention and prognosis of dementia.
*Metamemory training provides specific strategies for memory improvement in patients with early signs of cognitive decline (e.g., MCI) by strengthening the brain structure that is responsible for memory functions(i.e. hippocampus) and the integrated neural networks.
Software as a Medical Device
for enhancing early cognitive decline
Conversation-based interface using vocal cues,
made for the convenience of patients with early cognitive decline.
After accurate assessments of the patient’s cognitive ability, training contents are automatically generated via AI technology, providing personalized training with difficulty adjustments.
Frees the patient from restraints of professional presence, location, and time. Accessible anytime and anywhere.
We create technology
that helps sustain
About 10% of the senior population suffers from dementia. Yet, many patients begin to encounter issues with memory loss in the stage before dementia, known as Mild Cognitive Impairment (MCI).
In comparison to dementia, 25% of the senior population suffers from MCI.
Emocog currently develops Digital therapeutics,
aiming to enhance the cognitive functions of patients in an early stage of cognitive decline.
that can be trusted,
Managing, i.e., proactively taking care of and training cognitive function is just as important as medicine for dementia patients.
We came up with a digital therapeutics product with the concept of a 'digital coach' supporting patients in managing their cognitive functions, available anytime and anywhere.
Emocog provides reliable and personalized solutions to treat cognitive decline by training the brain using digital technology developed by dementia specialists.
based on world-class scientific results
The results of 20 years of research have been published in
5 leading SCI-indexed journals on brain disease.
*Science Citation Index (SCI): renowned journals carefully selected
based on a strict criteria among science and technology journals
Cogcare consists of Medi-ballet and MMT.
Medi-ballet is a ballet program for the elderly aiming to improve memory by training the body and memory.
Improve your symptoms and upgrade your quality of life with Medi Ballet.
MMT is a training program based on ‘metamemory’ that enhances the cognitive function of the elderly with the help of cognitive training experts.
Memory and cognitive enhancement program